Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Sale of 1,051 STOK shares, $27.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 1,051 | $27.5K |
| Sep 3, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 3,945 | $120.4K |
| Aug 19, 2026 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 10,000 | n/a |
| Aug 5, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 5,907 | $171.0K |
| Jul 6, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 6,728 | $219.4K |
| Jun 3, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 1,795 | $54.9K |
| May 5, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 2,243 | $73.5K |
| Apr 3, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 1,838 | $60.0K |
| Mar 19, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 3,577 | $117.1K |
| Mar 17, 2026 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 13,100 | n/a |